Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines
- PMID: 33223050
- DOI: 10.1016/j.ajo.2020.09.016
Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines
Comment in
-
Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.Am J Ophthalmol. 2021 Feb;222:400-401. doi: 10.1016/j.ajo.2020.09.015. Epub 2020 Nov 20. Am J Ophthalmol. 2021. PMID: 33228963 No abstract available.
Comment on
-
Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.Am J Ophthalmol. 2020 Nov;219:101-106. doi: 10.1016/j.ajo.2020.06.030. Epub 2020 Jun 28. Am J Ophthalmol. 2020. PMID: 32610049 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
